News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
826,205 Results
Type
Article (61495)
Company Profile (714)
Press Release (763964)
Multimedia
Podcasts (228)
Webinars (32)
Section
Business (227290)
Career Advice (3340)
Deals (39215)
Drug Delivery (172)
Drug Development (89127)
Employer Resources (197)
FDA (18153)
Job Trends (17081)
News (386162)
Policy (37829)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3033)
Academic (1)
Accelerated approval (48)
Adcomms (39)
Allergies (184)
Alliances (55369)
ALS (222)
Alzheimer's disease (1922)
Antibody-drug conjugate (ADC) (488)
Approvals (18436)
Artificial intelligence (744)
Autoimmune disease (302)
Automation (58)
Bankruptcy (405)
Best Places to Work (12630)
BIOSECURE Act (23)
Biosimilars (236)
Biotechnology (440)
Bladder cancer (194)
Brain cancer (80)
Breast cancer (786)
Cancer (6091)
Cardiovascular disease (520)
Career advice (2851)
Career pathing (48)
CAR-T (353)
CDC (74)
Celiac Disease (3)
Cell therapy (962)
Cervical cancer (47)
Clinical research (76561)
Collaboration (2230)
Company closure (7)
Compensation (1418)
Complete response letters (100)
COVID-19 (3019)
CRISPR (119)
C-suite (1181)
Cystic fibrosis (162)
Data (7918)
Decentralized trials (3)
Denatured (86)
Depression (183)
Dermatology (85)
Diabetes (622)
Diagnostics (7479)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (353)
Drug pricing (243)
Drug shortages (39)
Duchenne muscular dystrophy (302)
Earnings (99516)
Editorial (77)
Employer branding (24)
Employer resources (170)
Events (134147)
Executive appointments (1157)
FDA (21974)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1824)
Gene editing (258)
Generative AI (68)
Gene therapy (795)
GLP-1 (1238)
Government (5395)
Grass and pollen (8)
Guidances (412)
Healthcare (21027)
HIV (86)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (342)
Immuno-oncology (100)
Indications (181)
Infectious disease (3388)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (145)
Intellectual property (299)
Interviews (649)
IPO (17889)
IRA (61)
Job creations (4823)
Job search strategy (2309)
JPM (73)
Kidney cancer (21)
Labor market (106)
Layoffs (676)
Leadership (49)
Legal (9533)
Liver cancer (107)
Longevity (34)
Lung cancer (799)
Lymphoma (435)
Machine learning (62)
Management (65)
Manufacturing (1103)
MASH (202)
Medical device (15165)
Medtech (15281)
Mergers & acquisitions (22571)
Metabolic disorders (1666)
mRNA (240)
Multiple sclerosis (196)
NASH (24)
Neurodegenerative disease (460)
Neuropsychiatric disorders (122)
Neuroscience (3549)
Neurotech (1)
NextGen: Class of 2026 (7615)
Non-profit (5128)
Now hiring (78)
Obesity (813)
Opinion (364)
Ovarian cancer (222)
Pain (272)
Pancreatic cancer (308)
Parkinson's disease (382)
Partnered (36)
Patents (617)
Patient recruitment (694)
Peanut (67)
People (66272)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23763)
Phase 2 (33494)
Phase 3 (25149)
Pipeline (8545)
Policy (382)
Postmarket research (3061)
Preclinical (10293)
Press Release (72)
Prostate cancer (309)
Psychedelics (68)
Radiopharmaceuticals (350)
Rare diseases (1182)
Real estate (7021)
Recruiting (79)
Regulatory (28639)
Reports (66)
Research institute (2743)
Resumes & cover letters (528)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (191)
Series A (312)
Series B (224)
Service/supplier (27)
Sickle cell disease (120)
Special edition (31)
Spinal muscular atrophy (181)
Sponsored (52)
Startups (4255)
State (2)
Stomach cancer (21)
Supply chain (137)
Tariffs (104)
The Weekly (139)
Vaccines (1255)
Venture capital (122)
Weight loss (558)
Women's health (129)
Worklife (24)
Date
Last 7 days (1005)
Last 30 days (3272)
Last 365 days (32209)
2026 (12361)
2025 (32348)
2024 (37791)
2023 (42556)
2022 (53920)
2021 (58700)
2020 (57625)
2019 (51237)
2018 (39025)
2017 (36180)
2016 (36691)
2015 (42756)
2014 (37009)
2013 (32279)
2012 (34303)
2011 (34753)
2010 (33196)
Location
Africa (1055)
Alabama (100)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (48158)
Australia (8126)
California (13575)
Canada (3797)
China (1426)
Colorado (585)
Connecticut (599)
Delaware (412)
Europe (108572)
Florida (2015)
Georgia (444)
Hawaii (4)
Idaho (68)
Illinois (1135)
India (96)
Indiana (633)
Iowa (25)
Japan (541)
Kansas (138)
Kentucky (56)
Louisiana (46)
Maine (88)
Maryland (1660)
Massachusetts (9912)
Michigan (391)
Minnesota (754)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (147)
New Hampshire (91)
New Jersey (3630)
New Mexico (33)
New York (3565)
North Carolina (1835)
North Dakota (10)
Northern California (6705)
Ohio (418)
Oklahoma (26)
Oregon (53)
Pennsylvania (2700)
Puerto Rico (30)
Rhode Island (53)
South America (1458)
South Carolina (87)
South Dakota (2)
Southern California (5326)
Tennessee (214)
Texas (2179)
United States (48590)
Utah (408)
Vermont (1)
Virginia (347)
Washington D.C. (88)
Washington State (1121)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
826,205 Results for "amazon com inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Younet AI Partners with Perpetuals.com to License and Co-Develop Forgentiq.ai Sovereign LLM and Agentic Technology Platform
Strategic Partnership Positions Both Companies at the Forefront of Institutional-Grade Digital Asset Market Infrastructure Anthropic-Broadcom Landmark Deal Securing 3.5 Gigawatts of TPU Capacity Validates the AI Infrastructure Thesis and Confirms Announced Today Vision of Enterprise-Grade Private AI as the Defining Asset Class of This Decade
April 10, 2026
·
7 min read
Press Releases
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2025 Results with 58% Revenue Growth and Positive Normalized Operating Income
February 10, 2026
·
1 min read
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
Biotech Bay
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
NovaBay® Pharmaceuticals, Inc., a company developing and commercializing high-quality eyecare and wound care products, announces record ordered product sales during the month of April for its Avenova-branded eyecare products on Amazon.com, the Company’s largest sales channel.
May 7, 2024
·
4 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization
May 6, 2026
·
11 min read
Press Releases
Milestone Scientific Inc. Completes $2.15 Million Private Placement
April 21, 2026
·
4 min read
Press Releases
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
April 29, 2026
·
8 min read
Press Releases
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
April 14, 2026
·
6 min read
Press Releases
Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing
February 19, 2026
·
8 min read
1 of 82,621
Next
